BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells

Cytogenetic and Genome Research

Volumn 122, Issue 3-4, 2009, Pages 336-342

  Cabuy, E ^a,b   Newton, C ^a   Slijepcevic, P ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DNA; ENZYME; OLIGONUCLEOTIDE; RNA; SMALL INTERFERING RNA; TELOMERASE;

ANAPHASE; ARTICLE; BREAST CANCER; BREAST CELL; BREAST EPITHELIUM; CANCER SUSCEPTIBILITY; CHROMATIN; CHROMOSOMAL INSTABILITY; CHROMOSOME SIZE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GENE FUNCTION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA INTERFERENCE; TELOMERE; WESTERN BLOTTING;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE; DNA DAMAGE; DNA PRIMERS; EPITHELIAL CELLS; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, HUMAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TELOMERE; TRANSFECTION;

EID: 59649093839     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167820     Document Type: Article

References (27)

1. Al-Wahiby S, Slijepcevic P: Chromosomal aberrations involving telomeres in BRCA1 deficient human and mouse cell lines. Cytogenet Genome Res 109:491-496 (2005).
2. Aprelikova O, Kuthiala A, Bessho M, Ethier S, Liu ET: BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene 13:2487-2491 (1996).
3. Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM: Regulation of BRCA1 by protein degradation. Oncogene 18:6460-6468 (1999).
4. Bruun D, Folias A, Akkari Y, Cox Y, Olson S, Moses R: SiRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. DNA Repair 2:1007-1013 (2003).
5. Cabuy E, Newton C, Joksic G, Woodbine L, Koller B, et al: Accelerated telomere shortening and telomere abnormalities in radiosensitive cell lines. Radiat Res 164:53-62 (2005).
6. Deng CX, Brodie SG: Roles of BRCA1 and its interacting proteins. Bioessays 22:728-737 (2000).
7. Deng CX, Scott F: Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 19:1059-1064 (2000).
8. Deng CX, Wang RH: Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Gen 12:113-123 (2003).
9. French JD, Dunn J, Smart CE, Manning N, Brown MA: Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines. Genes Chromosomes Cancer 45:277-289 (2006).
10. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, et al: Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 98: 12683-12688 (2001).
11. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ 3rd, Cowan KH: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Diff 7:717-723 (1996).
12. Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610 (2002).
13. Herbert BS, Wright WE, Shay JW: Telomerase and breast cancer. Breast Cancer Res 3:146-149 (2001).
14. Huschtscha LI, Noble JR, Neumann AA, Moy EL, Barry P, et al: Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 58:3508-3512 (1998).
15. Li H, Lee TH, Avraham H: A novel tricomplex of BRCA1, Nmi and c-Myc inhibits c-Myc induced hTERT promoter activity in breast cancer. J Biol Chem 277:20965-20973 (2002).
16. McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, et al: Telomere length abnormalities in radiosensitive mammalian cells. Cancer Res 61:912-915 (2001).
17. McPherson JP, Lemmers B, Hirao A, Hakem A, Abraham J, et al: Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev 18:1144-1153 (2004).
18. McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, et al: A role for Brca1 in chromosome end maintenance. Hum Mol Genet 15: 831-838 (2006).
19. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM: Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 16:743-747 (1998).
20. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182 (2002).
21. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structure. Gen Dev 14:927-939 (2000).
22. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature 21:236-240 (1999).
23. Wu G, Jiang X, Lee WH, Chen PL: Assembly of functional ALT-associated leukaemia bodies requires Nijmegen Breakage syndrome 1. Cancer Res 63:2589-2595 (2003).
24. Xiong J, Fan S, Meng Q, Schramm L, Wang C, et al: BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 23:8668-8690 (2003).
25. Zhong Q, Chen CF, Li S, Chen Y, Wang CC, et al: Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285:747-750 (1999).
26. Zhou C, Liu J: Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells. Biochem Biophys Res Com 303:130-136 (2003).
27. Zhu XD, Kuster B, Mann M, de Petrini JHJ, de Lange T: Cell-cycle regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25:347-352 (2000).